# Automated Blood Collection Market > Automated Blood Collection Market Size, Growth Research Report By Type (Automated Blood Collection Devices, Automated Blood Collection Sets, Automated Blood Collection Tubes, Automated Blood Collection Consumables), By Application (Diagnostic Testing, Therapeutic Procedures, Blood Banking, Research and Development), By Technology (Vacuum-Based Devices, Syringe-Based Devices, Centrifugal Devices, Microneedle Devices), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Blood Banks, Research Institutes) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Competitor Industry Analysis and Trends Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.78% - **2024:** $ 4.16 Billion - **2025:** $ 4.48 Billion - **2035:** $ 9.48 Billion - **Key Players:** Terumo Corporation (JP), Fresenius Kabi AG (DE), Becton Dickinson and Company (US), Grifols S.A. (ES), Haemonetics Corporation (US), Kawasumi Laboratories, Inc. (JP), Blood Centers of America, Inc. (US), Mediware Information Systems, Inc. (US) **Report ID:** MRFR/HC/25203-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/automated-blood-collection-market-26865 --- ## Market Summary ## **Automated Blood Collection Market Overview** As per MRFR analysis, the Automated Blood Collection Market Size was estimated at 4.16 (USD Billion) in 2024. The Automated Blood Collection Market Industry is expected to grow from 4.48 (USD Billion) in 2025 to 8.80 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.78% during the forecast period (2025 - 2034). ## **Key Automated Blood Collection Market Trends Highlighted** Technological advancements, particularly in microfluidics and miniaturization, are driving innovation in the automated blood collection market. Integration with point-of-care (POC) testing systems enables real-time analysis and rapid diagnosis, enhancing patient care. Key market drivers include the rising prevalence of chronic diseases, increasing demand for blood transfusions, and the need for accurate and efficient blood collection methods. Opportunities arise from expanding healthcare infrastructure in emerging markets and the integration of artificial intelligence (AI) for automated blood collection and analysis. Recent trends include the adoption of finger-prick devices for non-invasive blood collection, the miniaturization of automated blood collection devices, and the emergence of wearable blood collection sensors for continuous monitoring. These innovations are expected to revolutionize blood collection and improve patient outcomes in the future. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ## **Automated Blood Collection Market Drivers** ### **Increasing Prevalence of Chronic Diseases** The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases, is a major driver of the Automated Blood Collection Market. These diseases require frequent blood tests for monitoring and diagnosis, which has led to an increased demand for automated blood collection systems. Automated blood collection systems offer several advantages over traditional manual methods, including reduced risk of contamination, improved accuracy, and faster processing times. As a result, these systems are increasingly being adopted by hospitals, clinics, and other healthcare facilities. ### **Technological Advancements** The Automated Blood Collection Market is also being driven by technological advancements. New technologies, such as microfluidics and robotics, are being used to develop more sophisticated and user-friendly automated blood collection systems. These systems can perform a wider range of tasks, such as sample preparation and analysis, which makes them more versatile and efficient. Additionally, the development of wireless and portable automated blood collection systems is making it easier to collect blood samples in remote or resource-limited settings. ### **Government Initiatives** Another factor contributing to the growth of the Automated Blood Collection Market is government actions aimed at improving healthcare infrastructure and access to healthcare services. Governments in various countries are providing funding and support for the development and deployment of automated blood collection systems, as they recognize their significance in enhancing the quality and efficiency of healthcare services. ## **Automated Blood Collection Market Segment Insights** ### **Automated Blood Collection Market Type Insights   ** The Automated Blood Collection Market is segmented by type into automated blood collection devices, automated blood collection sets, automated blood collection tubes, and automated blood collection consumables. In 2024, the automated blood collection devices segment is expected to dominate the market with a revenue of USD 1.81 billion, representing a market share of 40.2%. The growth of this segment can be attributed to the increasing adoption of these devices in hospitals, clinics, and blood banks due to their accuracy, efficiency, and reduced risk of contamination. Automated blood collection sets are expected to witness a significant growth rate during the forecast period, owing to the growing demand for blood transfusions and the need for efficient blood collection procedures. These sets are designed to simplify the blood collection process, reduce the risk of errors, and improve patient safety. Automated blood collection tubes are witnessing increasing adoption in clinical settings due to their ability to provide accurate and reliable blood samples. These tubes are pre-filled with anticoagulants and preservatives, which help in maintaining the integrity of the blood sample for longer periods. Automated blood collection consumables, including needles, syringes, and other accessories, are essential components of automated blood collection systems. The growth of this segment is driven by the increasing demand for these consumables in hospitals, clinics, and research laboratories. Overall, the type segment of the Automated Blood Collection Market is characterized by technological advancements, growing demand for efficient blood collection procedures, and increasing awareness about the benefits of automated systems. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ### **Automated Blood Collection Market Application Insights   ** The Automated Blood Collection Market has been segmented based on application into diagnostic testing, therapeutic procedures, blood banking, and research and development. In 2023, diagnostic testing application accounted for the largest share of the market, and it is expected to hold its position during the forecast period. The high growth of the segment is attributed to the increasing prevalence of chronic disease which, in turn, drives the demand for accurate and timely diagnosis of the disease. Therapeutic procedures is another major application of automated blood collection systems, and it is expected to grow at a significant rate in the upcoming years. The growing number of surgeries and the requirement for precise blood collection during surgical operations have positively influenced the adoption of automated blood collection systems in this segment. Blood banking applications also account for an important application segment of these systems. Automated blood collection systems have enabled us to ensure the safety and efficiency of blood transfusions by reducing the risk of contamination and errors. Another important application of this equipment is research and development. Research laboratories use automated blood collection systems for the collection of blood samples for various research purposes. The growing need for personalized medicine and the rising number of clinical trials are expected to drive the growth of this segment in the upcoming years. ### **Automated Blood Collection Market Technology Insights** The Automated Blood Collection Market segmentation by technology comprises vacuum-based devices, syringe-based devices, centrifugal devices, and microneedle devices. Among these, vacuum-based devices accounted for the largest revenue share in 2023, owing to their ease of use, reliability, and cost-effectiveness. Syringe-based devices are expected to witness significant growth over the forecast period due to their accuracy and ability to collect larger blood volumes. Centrifugal devices offer advantages such as reduced hemolysis and improved sample quality, driving their demand in research and diagnostic applications. Microneedle devices are gaining traction due to their minimally invasive nature and potential for self-collection, making them suitable for point-of-care testing and home healthcare settings. ### **Automated Blood Collection Market End-User Insights** The end-user segment of the Automated Blood Collection Market is categorized into hospitals and clinics, diagnostic laboratories, blood banks, and research institutes. Hospitals and clinics hold the largest market share due to the high volume of blood tests performed in these settings. Diagnostic laboratories also account for a significant share of the market, as they provide specialized blood testing services. Blood banks play a crucial role in collecting, storing, and distributing blood for transfusions, contributing to the market growth. Research institutes are actively involved in developing and utilizing automated blood collection systems for clinical research and drug discovery. The increasing prevalence of chronic diseases, the growing demand for personalized medicine, and advancements in blood analysis technologies are driving the growth of the automated blood collection market across these end-user segments. ### **Automated Blood Collection Market Regional Insights** The Automated Blood Collection Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest share of the market in 2023, owing to the presence of many hospitals and clinics, as well as a high adoption rate of advanced healthcare technologies. Europe is expected to be the second-largest market, followed by the APAC region. The APAC region is expected to witness significant growth over the forecast period, owing to the rising healthcare expenditure and increasing awareness of automated blood collection systems. South America and MEA regions are expected to account for a smaller share of the market due to lower healthcare spending and limited access to advanced healthcare technologies. Source Primary Research, Secondary Research, MRFR Database and Analyst Review ## **Automated Blood Collection Market Key Players and Competitive Insights** Major players in the automated blood collection market are constantly striving to gain a competitive edge by introducing innovative products and expanding their global reach. Leading Automated Blood Collection Market players are investing heavily in research and development to enhance the efficiency and accuracy of their products. The automated blood collection market development is driven by technological advancements and the increasing demand for automation in healthcare settings. The landscape of the automated blood collection market is highly competitive, with several key players vying for market share. Roche is a leading company in the market. The company offers a wide range of automated blood collection systems, including the cobas p 312 and cobas p 512. Roche has a strong global presence and is known for its innovative products and high-quality standards. The company is constantly expanding its product portfolio and investing in research and development to maintain its leadership position. BD is a major competitor in the automated blood collection market. The company offers a comprehensive range of blood collection products, including the BD Vacutainer and BD Vacutainer Plus. BD has a strong global presence and is known for its reliable products and customer service. The company is continuously developing new products and technologies to meet the evolving needs of its customers. ### **Key Companies in the Automated Blood Collection Market Include** ### Automated Blood Collection Market Industry Developments - **Q2 2024: BD Launches New Automated Blood Collection System for Diagnostic Labs** BD (Becton, Dickinson and Company) announced the launch of its latest automated blood collection system designed to improve sample consistency and reduce contamination risks in high-volume diagnostic laboratories. - **Q1 2024: Greiner Bio-One Unveils VACUETTE® EVOPROTECT Safety Blood Collection Set** Greiner Bio-One introduced the VACUETTE® EVOPROTECT Safety Blood Collection Set, a new device aimed at enhancing safety and efficiency in automated blood collection procedures for hospitals and clinics. - **Q2 2024: Qiagen Receives FDA Clearance for QIAstat-Dx Automated Blood Collection Module** Qiagen announced FDA clearance for its QIAstat-Dx automated blood collection module, enabling streamlined sample processing for infectious disease diagnostics in clinical laboratories. - **Q3 2024: Terumo Opens New Automated Blood Collection Device Manufacturing Facility in North Carolina** Terumo Corporation inaugurated a new manufacturing facility in North Carolina dedicated to producing automated blood collection devices, expanding its capacity to meet growing demand in the U.S. market. - **Q2 2024: Haemonetics Announces Strategic Partnership with Siemens Healthineers for Automated Blood Collection Solutions** Haemonetics entered into a strategic partnership with Siemens Healthineers to co-develop and market advanced automated blood collection solutions for hospitals and blood banks globally. - **Q1 2025: Fresenius Kabi Acquires Automated Blood Collection Startup HematoTech** Fresenius Kabi completed the acquisition of HematoTech, a startup specializing in automated blood collection technologies, to strengthen its portfolio in the blood management sector. - **Q2 2025: Bio-Rad Laboratories Launches Next-Generation Automated Blood Collection Analyzer** Bio-Rad Laboratories launched its next-generation automated blood collection analyzer, featuring integrated digital tracking and enhanced sample throughput for clinical diagnostics. - **Q1 2025: Abbott Receives CE Mark for Automated Blood Collection Device for European Market** Abbott announced it has received CE Mark approval for its new automated blood collection device, allowing commercial distribution across the European Union. - **Q2 2024: Sartorius and Roche Sign Collaboration Agreement for Automated Blood Collection Technology** Sartorius and Roche signed a collaboration agreement to jointly develop automated blood collection technology aimed at improving efficiency in clinical trial sample management. - **Q3 2024: Medtronic Invests $40 Million in Automated Blood Collection Device R&D** Medtronic announced a $40 million investment in research and development for its automated blood collection device platform, targeting improved patient outcomes and operational efficiency. - **Q2 2025: Sysmex Launches Automated Blood Collection System for Point-of-Care Diagnostics** Sysmex launched a new automated blood collection system designed for point-of-care diagnostics, enabling rapid and accurate sample collection in decentralized healthcare settings. - **Q1 2025: Beckman Coulter Appoints New CEO to Lead Automated Blood Collection Expansion** Beckman Coulter announced the appointment of a new CEO, tasked with driving the company's expansion in the automated blood collection market. ## **Automated Blood Collection Market Segmentation Insights** ### **Automated Blood Collection Market Type Outlook** ### **Automated Blood Collection Market Application Outlook** ### **Automated Blood Collection Market Technology Outlook** ### **Automated Blood Collection Market End-User Outlook** ### **Automated Blood Collection Market Regional Outlook** ## Market Drivers ### Supportive Regulatory Frameworks The Automated Blood Collection Market benefits from supportive regulatory frameworks that encourage the adoption of advanced blood collection technologies. Regulatory agencies are increasingly recognizing the importance of automation in enhancing the safety and efficiency of blood collection processes. Initiatives aimed at streamlining the approval process for new technologies are likely to foster innovation and investment in this sector. Furthermore, guidelines promoting the use of automated systems in clinical settings are expected to drive market growth. As regulations evolve to support technological advancements, the market could witness a surge in new product launches and increased competition among manufacturers, ultimately benefiting healthcare providers and patients alike. ### Increasing Focus on Patient Safety Patient safety remains a top priority within the Automated Blood Collection Market. The implementation of automated systems significantly reduces the risk of contamination and infection during blood collection procedures. As healthcare providers become more aware of the implications of unsafe practices, the demand for automated solutions is likely to rise. Regulatory bodies are also emphasizing the need for safer blood collection methods, which further propels market growth. Recent statistics indicate that hospitals adopting automated blood collection systems report a 25% decrease in infection rates associated with blood sampling. This focus on safety not only enhances patient trust but also aligns with broader healthcare initiatives aimed at improving quality of care. ### Growing Prevalence of Chronic Diseases The increasing prevalence of chronic diseases is a significant driver for the Automated Blood Collection Market. Conditions such as diabetes, cardiovascular diseases, and cancer require regular blood monitoring and testing. As the patient population for these diseases expands, the demand for efficient blood collection methods rises correspondingly. Healthcare facilities are increasingly adopting automated blood collection systems to manage the higher volume of tests required for [chronic disease management](https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981). Market analysis suggests that the segment related to chronic disease monitoring could see a growth rate of over 10% in the coming years. This trend underscores the necessity for healthcare systems to adapt to the changing landscape of patient care. ### Rising Demand for Efficient Blood Collection The Automated Blood Collection Market is experiencing a notable increase in demand for efficient blood collection methods. This trend is driven by the need for faster and more accurate blood sampling processes, which are essential in clinical settings. As healthcare facilities strive to enhance patient throughput and reduce waiting times, automated systems are becoming increasingly attractive. According to recent data, the market for automated blood collection devices is projected to grow at a compound annual growth rate of approximately 8% over the next five years. This growth is indicative of a broader shift towards automation in healthcare, where efficiency and precision are paramount. The integration of automated systems not only streamlines operations but also minimizes human error, thereby improving overall patient outcomes. ### Technological Innovations in Blood Collection Technological advancements play a crucial role in shaping the Automated Blood Collection Market. Innovations such as robotic systems, advanced software, and smart devices are transforming traditional blood collection methods. These technologies enhance the accuracy and reliability of blood sampling, which is vital for diagnostic purposes. For instance, automated blood collection systems equipped with artificial intelligence can analyze samples in real-time, providing immediate feedback to healthcare professionals. The market is witnessing a surge in the adoption of these technologies, with estimates suggesting that the segment could account for over 30% of the total market share by 2026. This shift towards high-tech solutions reflects a growing recognition of the importance of precision in medical diagnostics. ## Future Outlook The Automated Blood Collection Market is projected to grow at a 7.78% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for efficient blood collection, and rising healthcare expenditures. **New opportunities:** - Integration of AI for predictive analytics in blood collection processes. - Development of mobile blood collection units for remote areas. - Partnerships with healthcare providers for subscription-based blood collection services. By 2035, the market is expected to be robust, reflecting substantial growth and innovation. ## Segment Insights ### By Type: Automated Blood Collection Devices (Largest) vs. Automated Blood Collection Sets (Fastest-Growing) The Automated Blood Collection Market is primarily divided into four key segments: Automated Blood Collection Devices, Automated Blood Collection Sets, Automated Blood Collection Tubes, and Automated Blood Collection Consumables. Among these, Automated Blood Collection Devices hold the largest market share, reflecting their critical role in enhancing efficiency and accuracy in blood collection procedures. Meanwhile, Automated Blood Collection Sets are emerging as the fastest-growing segment, driven by increasing demand for integrated systems that streamline the blood collection process and enhance patient safety. Automated Blood Collection Devices (Dominant) vs. Automated Blood Collection Sets (Emerging) Automated Blood Collection Devices are characterized by their advanced technology and ease of use, making them indispensable in healthcare settings. They significantly enhance workflow efficiency and minimize human error during the blood collection process. On the other hand, Automated Blood Collection Sets are gaining popularity due to their convenience and ability to provide a comprehensive solution for healthcare providers. These sets are designed for optimal patient comfort and safety and are increasingly favored for their efficiency in sample collection and handling. As healthcare facilities continue to adopt technology to improve clinical outcomes, both segment values are expected to play crucial roles in shaping the future of the Automated Blood Collection Market. ### By Application: Blood Banking (Largest) vs. Diagnostic Testing (Fastest-Growing) The automated blood collection market is primarily driven by diverse applications, with blood banking emerging as the largest segment. This is attributed to the increasing demand for blood products and the need for efficient blood storage and processing solutions. Diagnostic testing follows closely, commanding a significant share due to the rising prevalence of chronic diseases and the growing emphasis on timely diagnostics in healthcare settings. Blood Banking (Dominant) vs. Diagnostic Testing (Emerging) Blood banking serves as the cornerstone of the automated blood collection market, as it supports the critical need for blood donation, storage, and transfusion processes. This segment is characterized by established technologies that enhance the safety and efficiency of blood handling. In contrast, diagnostic testing is gaining momentum as an emerging segment, driven by technological advancements and increasing integration of automated systems in laboratories. This segment facilitates rapid testing capabilities and improved patient outcomes, responding to the heightened demand for preventive healthcare solutions. ### By Technology: Vacuum-Based Devices (Largest) vs. Microneedle Devices (Fastest-Growing) The Automated Blood Collection Market exhibits a diversified technological landscape, with Vacuum-Based Devices commanding the largest market share. These devices are favored for their reliability and efficiency, allowing for the swift collection of blood samples with minimal discomfort to patients. In contrast, Microneedle Devices are rapidly gaining traction, attributed to their innovative approach that reduces pain and enhances patient compliance. The increasing emphasis on patient-centric solutions is propelling these emerging technologies to the forefront of the market. Growth trends reveal a significant shift towards minimally invasive techniques in the blood collection space. In particular, increasing awareness regarding the benefits of Microneedle Devices, such as reduced pain and improved user experience, has accelerated their adoption. Advances in technology, combined with supportive regulatory frameworks, are expected to facilitate sustained growth across this segment, making it a focal point for future investments and innovations. Technology: Vacuum-Based Devices (Dominant) vs. Microneedle Devices (Emerging) Vacuum-Based Devices are the cornerstone of blood collection technologies, recognized for their efficiency and high sample yield. Their design allows for safe, efficient collection of multiple blood samples without exposure to blood, making them a preferred choice in clinical settings. As the dominant technology in the Automated Blood Collection Market, they have established reliability and have a strong market presence. Conversely, Microneedle Devices represent an emerging technology that is revolutionizing how blood is collected. These pioneering devices utilize micro-sized needles to access capillaries, drastically reducing pain and invasiveness. The growing demand for user-friendly and less painful blood collection methods positions Microneedle Devices as strong competitors, poised to carve a significant niche in the market over the coming years. ### By End-User: Hospitals and Clinics (Largest) vs. Blood Banks (Fastest-Growing) In the Automated Blood Collection Market, hospitals and clinics represent the largest segment, accounting for a substantial portion of the total market share. This dominance is driven by the high volume of blood collection procedures performed in these facilities, as they cater to a broad patient base requiring diagnostic tests and treatments. Diagnostic laboratories and research institutes also play significant roles in the market, though their shares are comparatively smaller as they focus on specific testing and research activities rather than routine blood collection. The growth trends within this segment highlight a robust surge in demand for automated blood collection solutions, particularly in blood banks, which have emerged as the fastest-growing segment. This increase can be attributed to the rising need for efficient blood donation processes and management systems, spurred by growing awareness of blood donation and the expanding need for blood products in various medical treatments. Technological advancements and an increasing focus on automation in blood collection processes have further fueled this growth, suggesting a promising outlook for the automated blood collection market in these end-user categories. Hospitals and Clinics (Dominant) vs. Research Institutes (Emerging) Hospitals and clinics are the dominant players in the Automated Blood Collection Market, primarily due to their necessity to conduct large volumes of blood tests for diagnosis, treatment, and monitoring. They benefit from established relationships with patients, allowing for regular blood donations and testing, which keeps their operations steady and profitable. In contrast, research institutes are positioned as an emerging segment, utilizing automated blood collection systems mainly for specialized studies and trials. Although they currently hold a smaller market share, their significance is growing as advancements in technology allow for more sophisticated research that requires precise and efficient blood sample collection. This shift signals a potential for increased investment and innovation in automated systems tailored to the needs of research environments. ## Regional Market Share Analysis ### North America : Innovation and Demand Surge North America is the largest market for automated blood collection, holding approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing demand for blood products, and stringent regulatory standards that promote safety and efficiency. The presence of key players like Becton Dickinson and Company and Haemonetics Corporation further fuels market expansion, supported by government initiatives to enhance blood donation processes. The United States dominates this market, accounting for the majority of the share, followed by Canada. The competitive landscape is characterized by significant investments in technology and innovation, with companies focusing on developing automated systems that improve collection efficiency and donor experience. Regulatory bodies in the U.S. ensure compliance with safety standards, which is crucial for market growth. ### Europe : Regulatory Framework and Growth Europe is witnessing significant growth in the automated blood collection market, holding around 30% of the global share. The region benefits from a robust healthcare system and increasing awareness about the importance of blood donation. Regulatory frameworks, such as the European Blood Directive, promote the use of automated systems to enhance safety and efficiency in blood collection processes, driving demand across member states. Leading countries in this region include Germany, France, and the UK, where key players like Fresenius Kabi AG and Grifols S.A. are actively involved. The competitive landscape is marked by collaborations and partnerships aimed at advancing technology in blood collection. The European market is characterized by a focus on innovation and compliance with stringent regulations, ensuring high standards in blood safety and donor care. ### Asia-Pacific : Rapid Growth and Adoption Asia-Pacific is rapidly emerging as a significant player in the automated blood collection market, accounting for approximately 20% of the global share. The region's growth is driven by increasing healthcare investments, rising population awareness about blood donation, and government initiatives to improve blood collection processes. Countries like China and India are leading this growth, supported by favorable regulations that encourage the adoption of automated technologies. China is the largest market in this region, followed by India and Japan. The competitive landscape is evolving, with local and international players like Terumo Corporation and Kawasumi Laboratories, Inc. expanding their presence. The focus on technological advancements and improving donor experiences is shaping the market, as stakeholders aim to enhance efficiency and safety in blood collection practices. ### Middle East and Africa : Emerging Market with Challenges The Middle East and Africa region is gradually developing its automated blood collection market, holding about 5% of the global share. The growth is primarily driven by increasing healthcare investments and a rising demand for blood products. However, challenges such as regulatory hurdles and limited infrastructure in certain areas hinder rapid market expansion. Countries like South Africa and the UAE are at the forefront of this growth, with initiatives aimed at improving blood donation processes. In South Africa, the presence of organizations like Blood Centers of America, Inc. is pivotal in promoting automated blood collection. The competitive landscape is characterized by a mix of local and international players striving to enhance blood collection efficiency. As governments focus on improving healthcare systems, the market is expected to witness gradual growth, driven by technological advancements and increased public awareness about blood donation. ## Competitive Benchmarking The Automated Blood Collection Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for efficient blood collection methods. Key players such as Terumo Corporation (Japan), Fresenius Kabi AG (Germany), and Becton Dickinson and Company (United States) are strategically positioned to leverage innovation and expand their market presence. Terumo Corporation (Japan) focuses on enhancing its product offerings through continuous research and development, while Fresenius Kabi AG (Germany) emphasizes strategic partnerships to bolster its operational capabilities. Becton Dickinson and Company (United States) is actively pursuing digital transformation initiatives to streamline processes and improve customer engagement. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and operational efficiency.In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain resilience. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of key players is substantial, as they set industry standards and drive technological advancements. This competitive structure fosters an environment where innovation is paramount, compelling companies to continuously adapt and refine their strategies to maintain relevance. In August Terumo Corporation (Japan) announced the launch of a new automated blood collection system designed to enhance user experience and improve collection efficiency. This strategic move is significant as it not only reinforces Terumo's commitment to innovation but also positions the company to capture a larger share of the growing market. The introduction of this advanced system is likely to attract healthcare providers seeking to optimize their blood collection processes, thereby enhancing patient care. In September Fresenius Kabi AG (Germany) entered into a strategic partnership with a leading technology firm to develop AI-driven solutions for blood collection and management. This collaboration is indicative of the increasing importance of digitalization in the healthcare sector. By integrating AI technologies, Fresenius Kabi AG aims to improve operational efficiency and patient outcomes, which could provide a competitive edge in a rapidly evolving market. In July Becton Dickinson and Company (United States) expanded its manufacturing capabilities by investing in a new facility dedicated to automated blood collection technologies. This expansion is a strategic response to the rising demand for blood collection solutions and reflects the company's commitment to enhancing its production capacity. By increasing its manufacturing footprint, Becton Dickinson and Company is likely to improve supply chain reliability and meet the growing needs of healthcare providers. As of October current competitive trends in the Automated Blood Collection Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming increasingly prevalent, as companies recognize the value of collaboration in driving innovation and enhancing operational capabilities. Looking ahead, it is anticipated that competitive differentiation will evolve, shifting from traditional price-based competition to a focus on technological innovation, supply chain reliability, and enhanced patient care solutions. This transition underscores the necessity for companies to remain agile and responsive to the changing demands of the market. ## Recent News & Developments - **Q2 2024: BD Launches New Automated Blood Collection Market System for Diagnostic Labs** BD (Becton, Dickinson and Company) announced the launch of its latest automated blood collection system designed to improve sample consistency and reduce contamination risks in high-volume diagnostic laboratories. - **Q1 2024: Greiner Bio-One Unveils VACUETTE® EVOPROTECT Safety Blood Collection Set** Greiner Bio-One introduced the VACUETTE® EVOPROTECT Safety Blood Collection Set, a new device aimed at enhancing safety and efficiency in automated blood collection procedures for hospitals and clinics. - **Q2 2024: Qiagen Receives FDA Clearance for QIAstat-Dx Automated Blood Collection Market Module** Qiagen announced FDA clearance for its QIAstat-Dx automated blood collection module, enabling streamlined sample processing for infectious disease diagnostics in clinical laboratories. - **Q3 2024: Terumo Opens New Automated Blood Collection Market Device Manufacturing Facility in North Carolina** Terumo Corporation inaugurated a new manufacturing facility in North Carolina dedicated to producing automated blood collection devices, expanding its capacity to meet growing demand in the U.S. market. - **Q2 2024: Haemonetics Announces Strategic Partnership with Siemens Healthineers for Automated Blood Collection Market Solutions** Haemonetics entered into a strategic partnership with Siemens Healthineers to co-develop and market advanced automated blood collection solutions for hospitals and blood banks globally. - **Q1 2025: Fresenius Kabi Acquires Automated Blood Collection Market Startup HematoTech** Fresenius Kabi completed the acquisition of HematoTech, a startup specializing in automated blood collection technologies, to strengthen its portfolio in the blood management sector. - **Q2 2025: Bio-Rad Laboratories Launches Next-Generation Automated Blood Collection Market Analyzer** Bio-Rad Laboratories launched its next-generation automated blood collection analyzer, featuring integrated digital tracking and enhanced sample throughput for [clinical diagnostics](https://www.marketresearchfuture.com/reports/clinical-diagnostic-market-41770). - **Q1 2025: Abbott Receives CE Mark for Automated Blood Collection Market Device for European Market** Abbott announced it has received CE Mark approval for its new automated blood collection device, allowing commercial distribution across the European Union. - **Q2 2024: Sartorius and Roche Sign Collaboration Agreement for Automated Blood Collection Market Technology** Sartorius and Roche signed a collaboration agreement to jointly develop automated blood collection technology aimed at improving efficiency in clinical trial sample management. - **Q3 2024: Medtronic Invests $40 Million in Automated Blood Collection Market Device R&D** Medtronic announced a $40 million investment in research and development for its automated blood collection device platform, targeting improved patient outcomes and operational efficiency. - **Q2 2025: Sysmex Launches Automated Blood Collection Market System for Point-of-Care Diagnostics** Sysmex launched a new automated blood collection system designed for point-of-care diagnostics, enabling rapid and accurate sample collection in decentralized healthcare settings. - **Q1 2025: Beckman Coulter Appoints New CEO to Lead Automated Blood Collection Market Expansion** Beckman Coulter announced the appointment of a new CEO, tasked with driving the company's expansion in the automated blood collection market. ## Report Scope | MARKET SIZE 2024 | 4.157(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 4.48(USD Billion) | | MARKET SIZE 2035 | 9.48(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.78% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Terumo Corporation (JP), Fresenius Kabi AG (DE), Becton Dickinson and Company (US), Grifols S.A. (ES), Haemonetics Corporation (US), Kawasumi Laboratories, Inc. (JP), Blood Centers of America, Inc. (US), Mediware Information Systems, Inc. (US) | | Segments Covered | Type, Application, Technology, End-User, Region | | Key Market Opportunities | Integration of artificial intelligence in Automated Blood Collection systems enhances efficiency and accuracy. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and efficiency in the Automated Blood Collection Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Automated Blood Collection Market by 2035?** A: The projected market valuation for the Automated Blood Collection Market is expected to reach 9.48 USD Billion by 2035. **Q: What was the market valuation of the Automated Blood Collection Market in 2024?** A: The overall market valuation of the Automated Blood Collection Market was 4.157 USD Billion in 2024. **Q: What is the expected CAGR for the Automated Blood Collection Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Automated Blood Collection Market during the forecast period 2025 - 2035 is 7.78%. **Q: Which companies are considered key players in the Automated Blood Collection Market?** A: Key players in the Automated Blood Collection Market include Terumo Corporation, Fresenius Kabi AG, Becton Dickinson and Company, Grifols S.A., and Haemonetics Corporation. **Q: What segment of the Automated Blood Collection Market is projected to grow the most by 2035?** A: The Automated Blood Collection Devices segment is projected to grow from 1.5 USD Billion in 2024 to 3.5 USD Billion by 2035. **Q: How much is the Automated Blood Collection Sets segment expected to be valued at by 2035?** A: The Automated Blood Collection Sets segment is expected to reach a valuation of 2.8 USD Billion by 2035. **Q: What is the anticipated growth for the Diagnostic Testing application in the Automated Blood Collection Market?** A: The Diagnostic Testing application is projected to grow from 1.5 USD Billion in 2024 to 3.5 USD Billion by 2035. **Q: Which technology segment is expected to see significant growth in the Automated Blood Collection Market?** A: The Vacuum-Based Devices segment is anticipated to grow from 1.5 USD Billion in 2024 to 3.5 USD Billion by 2035. **Q: What is the expected valuation for the Blood Banking application by 2035?** A: The Blood Banking application is expected to reach a valuation of 2.5 USD Billion by 2035. **Q: Which end-user segment is projected to have the highest growth in the Automated Blood Collection Market?** A: The Hospitals and Clinics end-user segment is projected to grow from 1.5 USD Billion in 2024 to 3.5 USD Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/automated-blood-collection-market-26865*